Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne L Blum

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Proceedings (Baylor University. Medical Center)|October 13, 2023
On grief, ghosts, and gallantryJoanne L Blum
Proceedings (Baylor University. Medical Center)|August 18, 2025
BoundariesJoanne L Blum
Clinical Breast Cancer|June 13, 2006
Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancerJoyce A O'Shaughnessy, Joanne L Blum
Cancer|September 16, 2003
Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinomaPierre Fumoleau, Joanne L Blum, Peter Reichardt
Breast Cancer Research and Treatment|January 10, 2017
The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapyEdward J Pearson, Anju Nair, Yahya Daoud, et al.
Clinical Breast Cancer|August 23, 2011
Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancerRobert Leonard, Bryan T Hennessy, Joanne L Blum, et al.
Proceedings (Baylor University. Medical Center)|August 7, 2019
Barriers to the utilization of genetic testing and genetic counseling in patients with suspected hereditary breast and ovarian cancersAlicia Swink, Anju Nair, Pamela Hoof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast CancerJoanne L Blum, Nicholas Robert, Jay Andersen, et al.
Journal of Genetic Counseling|December 18, 2004
Family environments of women seeking BRCA1/BRCA2 genetic mutation testing: an exploratory analysisLisa A Keenan, Karen T Lesniak, Charles A Guarnaccia, et al.
Breast Cancer Research and Treatment|November 3, 2010
Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trialsJoanne L Blum, Joseph Kohles, Edward McKenna, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Proceedings (Baylor University. Medical Center)|October 13, 2023
On grief, ghosts, and gallantryJoanne L Blum
Proceedings (Baylor University. Medical Center)|August 18, 2025
BoundariesJoanne L Blum
Clinical Breast Cancer|June 13, 2006
Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancerJoyce A O'Shaughnessy, Joanne L Blum
Cancer|September 16, 2003
Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinomaPierre Fumoleau, Joanne L Blum, Peter Reichardt
Breast Cancer Research and Treatment|January 10, 2017
The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapyEdward J Pearson, Anju Nair, Yahya Daoud, et al.
Clinical Breast Cancer|August 23, 2011
Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancerRobert Leonard, Bryan T Hennessy, Joanne L Blum, et al.
Proceedings (Baylor University. Medical Center)|August 7, 2019
Barriers to the utilization of genetic testing and genetic counseling in patients with suspected hereditary breast and ovarian cancersAlicia Swink, Anju Nair, Pamela Hoof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast CancerJoanne L Blum, Nicholas Robert, Jay Andersen, et al.
Journal of Genetic Counseling|December 18, 2004
Family environments of women seeking BRCA1/BRCA2 genetic mutation testing: an exploratory analysisLisa A Keenan, Karen T Lesniak, Charles A Guarnaccia, et al.
Breast Cancer Research and Treatment|November 3, 2010
Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trialsJoanne L Blum, Joseph Kohles, Edward McKenna, et al.
Pageof 8